These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 841097)
41. Treatment of acute myocardial infarction with propranolol. Snow PJ Am J Cardiol; 1966 Sep; 18(3):458-62. PubMed ID: 5922890 [No Abstract] [Full Text] [Related]
42. Propranolol and experimental myocardial infarction: substrate effects. Opie LH; Thomas M Postgrad Med J; 1976; 52 Suppl 4():124-32. PubMed ID: 787952 [TBL] [Abstract][Full Text] [Related]
43. A guide to the use of propranolol in five cardiac conditions. LeWinter MM Med Times; 1978 Aug; 106(8):44-9. PubMed ID: 150482 [No Abstract] [Full Text] [Related]
44. [Stimulation of cardiac lymphatic drainage by obzidan, heparin and rheogluman in acute myocardial ischemia]. Mamedov IaD; Ismailova ZD; Garaev GSh; Mirzabekova FI Biull Eksp Biol Med; 1990 Nov; 110(11):460-2. PubMed ID: 1707317 [TBL] [Abstract][Full Text] [Related]
50. [Comparative effects of obsidan and isoptin on the size of myocardial infarction]. Agaev MM Kardiologiia; 1984 Oct; 24(10):63-6. PubMed ID: 6521185 [No Abstract] [Full Text] [Related]
51. Beta-Blockers in the management of myocardial ischemia. Davies RO Adv Cardiol; 1974; 13():315-29. PubMed ID: 4155918 [No Abstract] [Full Text] [Related]
52. Intravenous propranolol in acute myocardial infarction. Norris RM; Brown MA Lancet; 1985 Jan; 1(8419):56. PubMed ID: 2856987 [No Abstract] [Full Text] [Related]
53. The use of propranolol (inderal) in acute myocardial infarction. Dotremont G; De Geest H Acta Clin Belg; 1968; 23(3):163-76. PubMed ID: 4890367 [No Abstract] [Full Text] [Related]
54. Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction? Silke B; Verma SP; Ahuja RC; Hussain M; Hafizullah M; Reynolds G; Nelson GI; Taylor SH Eur J Clin Pharmacol; 1984; 27(5):509-15. PubMed ID: 6151504 [TBL] [Abstract][Full Text] [Related]
55. [Effect of the beta-blocker propranolol (obzidan) on the content of macroergic phosphates and the development of the size of necrotic areas in the myocardium in experimental acute coronary occlusion]. Irgashev ShB; Mavridi DI; Iuldashev NM Kardiologiia; 1988 Aug; 28(8):86-90. PubMed ID: 3199662 [TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death. Shand DG; Pritchett EL; Hammill SC; Stargel WW; Wagner GS Ann N Y Acad Sci; 1982; 382():238-46. PubMed ID: 7044243 [No Abstract] [Full Text] [Related]
57. Myocardial ischemia (third of three parts). Hillis LD; Braunwald E N Engl J Med; 1977 May; 296(19):1093-6. PubMed ID: 403473 [No Abstract] [Full Text] [Related]
58. The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations. Thomas M Acta Med Scand Suppl; 1976; 587():185-91. PubMed ID: 3097 [No Abstract] [Full Text] [Related]
59. Trial of propranolol in acute myocardial infarction. Norris RM; Caughey DE; Scott PJ Br Med J; 1968 May; 2(5602):398-400. PubMed ID: 4870075 [No Abstract] [Full Text] [Related]
60. [Intravenous administration of propranolol in the acute period of myocardial infarct]. Gratsianskiĭ NA; Karpov IuA; Evdokimov VV; Bunaeva VE Ter Arkh; 1980; 52(10):33-9. PubMed ID: 7444780 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]